Recognition of dengue virus NS1-MS2a proteins by human CD4+ cytotoxic T lymphocyte clones

Virology

Volumn 234, Issue 2, 1997, Pages 383-386

  Green, Sharone ^a   Kurane, Ichiro ^a   Pincus, Steven ^b   Paoletti, Enzo ^b   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Virogenetics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA DR ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENGUE VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

DENGUE VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0030790236     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8648     Document Type: Article

References (25)

1. Monath T. P. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA. 91:1994;2395-2400.
2. Henchal E. A., Putnak J. R. The dengue viruses. Clin. Micrbiol. Rev. 3:1990;376-396.
3. Sabin A. B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1:1952;30-50.
4. Halstead S. B., Nimmannitya S., Cohen S. N. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J. Biol. Med. 42:1970;311-328.
5. Kurane I., Innis B. L., Nisalak A., Hoke C., Nimmannitya S., Meager A., Ennis F. A. Human T cell responses to dengue virus antigens. J. Clin. Invest. 83:1989;506-513.
6. Kurane I., Meager A., Ennis F. A. Dengue virus-specific human T cell clones. J. Exp. Med. 170:1989;763-775.
7. Kurane I., Ennis F. A. Cytotoxic T lymphocytes in dengue virus infection. Curr. Top. Microbiol. Immunol. 189:1994;93-108.
8. Livingston P. G., Kurane I., Lai C.-J., Bray M., Ennis F. A. Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T cell clones. J. Virol. 68:1994;3283-3288.
9. Kurane I., Brinton M. A., Samson A. L., Ennis F. A. Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: Multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J. Virol. 65:1991;1823-1828.
10. Gagnon S. J., Zeng W., Kurane I., Ennis F. A. Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones. J. Virol. 70:1996;141-147.
11. Green S., Kurane I., Edelman R., Tacket C. O., Eckels K. H., Vaughn D. W., Hoke C. H. Jr., Ennis F. A. Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: Bulk culture proliferation, clonal analysis, and precursor frequency determination. J. Virol. 67:1993;5962-5967.
12. Edelman R., Tacket C. O., Wasserman S. S., Vaughn D. W., Eckels K. H., Dubois D. R., Summers P. L., Hoke C. H. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J. Infect. Dis. 170:1994;1448-1455.
13. Fonseca B. A. L., Pincus S., Shope R. E., Paoletti E., Mason P. W. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine. 12:1994;279-285.
14. Mathew A., Kurane I., Rothman A. L., Zeng L.-L., Brinton M. A., Ennis F. A. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J. Clin. Invest. 98:1996;1684-1692.
15. Zivny J., Kurane I., Tacket C. O., Edelman R., Ennis F. A. Dengue virus-specific, human CD4+ cytotoxic T lymphocytes generated in short-term culture. Viral Immunol. 6:1993;143-151.
16. Kurane I., Okamoto Y., Dai L.-C., Zeng L.-L., Brinton M. A., Ennis F. A. Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8- cytotoxic T lymphocyte clones. J. Gen. Virol. 76:1995;2243-2249.
17. Mason P. W., McAda P. C., Mason T. L., Fournier M. J. Sequence of the dengue-1 virus genome in the region encoding the three structural proteins and the major nonstructural protein NS1. Virology. 161:1987;262-267.
18. Fu J., Tan B.-H., Yap E.-H., Chan Y.-C., Tan Y. H. Full-length cDNA sequence of dengue type 1 virus (Singapore strain S275/90). Virology. 188:1992;953-958.
19. Mackenzie J. M., Jones M. K., Young P. R. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology. 220:1996;232-240.
20. Schlesinger J. J., Brandriss M. W., Walsh E. E. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J. Gen. Virol. 68:1987;852-857.
21. Henchal E. A., Henchal L. S., Schlesinger J. J. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen. Virol. 69:1988;2101-2107.
22. Rothman A. L., Kurane I., Ennis F. A. Multiple specificities in the murine CD4+ and CD8+ T-cell responses to dengue virus. J. Virol. 70:1996;6540-6546.
23. Falgout B., Bray M., Schlesinger J. J., Lai C.-J. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64:1990;4356-4363.
24. Falgout B., Chanock R., Lai C.-J. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J. Virol. 63:1989;1852-1860.
25. Leblois H., Young P. R. Maturation of the dengue-2 virus NS1 protein in insect cells: effects of downstream NS2A sequences on baculovirus-expressed gene constructs. J. Gen. Virol. 76:1995;979-984.